Chloroquine And Hydroxychloroquine - A Ray Of Hope

Published April 1, 2020 by pharmaffiliates

It is evident; there are no specific drugs for COVID-19. Scientists and researchers around the globe are leaving no stone unturned to find a cure for deadly coronavirus. Also, the entire human race for the first time in the history of civilization are yearning to hear “COVID 19 can be treated”.

Thousands are dying, millions are in isolation, hospitals staff and doctors are overloaded with work, world leaders are trying their best to lead the nations and protect people and trillions are under lockdown. The current situation forces us to feel that is this the end of human civilization?

Amidst such grim situation, USFDA has given us a ray of hope. The U.S. Department of Health and Human Services (HHS) said in a statement that chloroquine and hydroxychloroquine could be prescribed to teens and adults with COVID-19 "as appropriate, when a clinical trial is not available or feasible," after the FDA issued an Emergency Use Authorization.

Originally, Chloroquine was first used as prophylaxis and treatment for malaria. Hydroxychloroquine is a more soluble and less toxic metabolite of chloroquine, which causes less side effects and is safer.

Malarial is a parasitic infection and viral and parasitic infections are quite different. However, scientists believe that the chloroquines can change the acidity at the surface of the cell, thereby preventing the virus from infecting it.

Pharmaffiliates Analytics and Synthetic Pvt. Ltd providesHydroxychloroquin and Chloroquine for the research on COVID 19.

All the Impurities, metabolites, intermediates, chiral standards and isotope labeled compounds of chloroquine and hydroxychloroquine are also available with Pharmaffiliates.

In this fluid and harsh situation, Pharmaffiliates is operating its business as usual taking all the necessary precautions. You can contact our corporate office for all the enquiries.